Advertisement
Letter to the Editor| Volume 30, ISSUE 12, P1351-1352, December 2022

Download started.

Ok

Cognitive Impairment After Stroke and Treatment With Fluoxetine: A Planned Analysis of the AFFINITY Randomized Controlled Trial

Published:August 19, 2022DOI:https://doi.org/10.1016/j.jagp.2022.08.002
      Strokes increase the risk of cognitive impairment and dementia, and the risk of poststroke cognitive decline does not suside with time.
      • Koton S
      • Pike JR
      • Johansen M
      • et al.
      Association of ischemic stroke incidence, severity, and recurrence with dementia in the Atherosclerosis Risk in Communities Cohort Study.
      Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine, display neuroprotective, and neuroregenerative properties in animal models of brain ischemia,
      • Li WL
      • Cai HH
      • Wang B
      • et al.
      Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke.
      raising hope that their use could lessen the detrimental effects of stroke on cognition.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Geriatric Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Koton S
        • Pike JR
        • Johansen M
        • et al.
        Association of ischemic stroke incidence, severity, and recurrence with dementia in the Atherosclerosis Risk in Communities Cohort Study.
        JAMA Neurol. 2022; 79: 271-280
        • Li WL
        • Cai HH
        • Wang B
        • et al.
        Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke.
        J Neurosci Res. 2009; 87: 112-122
        • AFFINITY Trial Collaboration
        Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
        Lancet Neurol. 2020; 19: 651-660
        • de Jager CA
        • Budge MM
        • Clarke R
        Utility of TICS-M for the assessment of cognitive function in older adults.
        Int J Geriatr Psychiatry. 2003; 18: 318-324
        • Almeida OP
        • Hankey GJ
        • Ford A
        • et al.
        Depression outcomes among patients treated with fluoxetine for stroke recovery: the AFFINITY randomized clinical trial.
        JAMA Neurol. 2021; 78: 1072-1079